Bielefeld Pub
metadata only
Long-Term Uveitis Rates with Bimekizumab Treatment Across Pooled Phase 2B and Phase 3 Studies in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: 3-Year Update
Rudwaleit M, van der Horst-Bruinsma I, van Gaalen FA, et al. Long-Term Uveitis Rates with Bimekizumab Treatment Across Pooled Phase 2B and Phase 3 Studies in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: 3-Year Update. Journal of Rheumatology. 2026;53(Suppl. 1):53.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis#1162443
- Photodynamic Therapy for the Prevention of Lung Cancer#980454
- Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy#993675
- Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma#861164
- A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis#1183122
Record · ID 1278868
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive